HIV Type 1 Replication in Cerebrospinal Fluid of Patients with AIDS-Related Non-Hodgkin's Lymphoma Receiving Chemotherapy and Antiretroviral Therapy

AIDS Research and Human Retroviruses

Volumn 19, Issue 12, 2003, Pages 1091-1095

  Giancola, Maria Letizia ^a   Uccella, Ilaria ^a   Alba, Lucia ^a   Lorenzini, Patrizia ^a   Soldani, Fabio ^a   Capobianchi, Maria ^a   Ruco, Luigi ^b   Perno, Carlo Federico ^a   Antinori, Andrea ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; CYCLOPHOSPHAMIDE; DIDANOSINE; DOXORUBICIN; EFAVIRENZ; GRANULOCYTE COLONY STIMULATING FACTOR; INDINAVIR; LAMIVUDINE; LOPINAVIR; METHOTREXATE; NELFINAVIR; PREDNISOLONE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; TENOFOVIR; VINCRISTINE; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM METASTASIS; CEREBROSPINAL FLUID; CLINICAL ARTICLE; COMORBIDITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE DEFICIENCY; IMMUNOLOGY; INFECTION CONTROL; MALE; NONHODGKIN LYMPHOMA; NONHUMAN; POPULATION DYNAMICS; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTI-HIV AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; RNA, VIRAL; VIRAL LOAD; VIRUS REPLICATION;

EID: 0347992804     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203771881185     Document Type: Article

References (20)

1. Beral V, Peterman TA, Berkelman R, and Jaffe H: AIDS-associated non-Hodgkin lymphoma. Lancet 1991;337:805-809.
2. Kirk O, Pedersen C, Cozzi-Lepri A, et al.: Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 2001;98:3406-3412.
3. Mackall C, Fleisher T, Brown M, et al.: Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 1994; 84:2221-2228.
4. Zanussi S, Simonelli C, D'Andrea M, et al.: The effects of antineoplastic chemotherapy on HIV disease. AIDS Res Hum Retroviruses 1996;12:1703-1707.
5. Ratner L, Lee J, Tang, S, et al.: Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol 2001;19:2171-2178.
6. Antinori A, Cingolani A, Alba L, et al.: Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS 2001;15: 1483-1491.
7. Powles T, Imami N, Nelson M, Gazzard BG, and Bower M: Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma. AIDS 2002;16:531-536.
8. Staprans S, Marlowe N, Glidden D, et al.: Time course of cerebrospinal fluid responses to antiretroviral therapy: Evidence for variable compartmentalizarion of infection. AIDS 1999;13:1051-1061.
9. Ellis RJ, Gamst AC, Capparelli E, et al.: Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 2000;54:927-936.
10. Antinori A, Giancola ML, Grisetti S, et al.: Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1-infected patients. AIDS 2002;16:1867-1876.
11. Cingolani A, Gastaldi R, Fassone L, et al.: Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas. J Clin Oncol 2000;18:3325-3330.
12. García F, Niebla G, Romeu J, et al.: Cerebrospinal fluid HIV-1 RNA levels in asymptomatic patients with early stage chronic HIV-1 infection: Support for the hypothesis of local virus replication. AIDS 1999;13:1491-1496.
13. Little R, Pearson D, Gutierrez M, Steinberg S, Yarchoan R, and Wilson W: Dose-adjusted chemotherapy with suspension of antiretroviral therapy for HIV-associated non-Hodgkin's lymphoma. J Acquir Immune Defic Syndr 2000;23:A11.
14. Bergamini A, Perno CF, Balzarini J, et al.: Selective inhibition of HIV replication by adriamycin in macrophages but not in lymphocytes. AIDS Res Hum Retroviruses 1992;8:1239-1247.
15. Jeyaseelan R, Kurabayashi M, and Kedes L: Doxorubicin inhibits Tat-dependent transactivation of HIV type 1 LTR. AIDS Res Hum Retroviruses 1996;12:569-576.
16. Enting RH, Hoetelmans RM, Lange JM, Burger DM, Beijnen JH, and Portegies P: Antiretroviral drugs and the central nervous system. AIDS 1998;12:1941-1955.
17. Gisslen M and Hagberg L: Antiretroviral treatment of central nervous system HIV-1 infection: A review. HIV Med 2001;2:97-104.
18. De Luca A, Ciancio BC, Larussa D, et al.: Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals. Neurology 2002;59:342-347.
19. Sacktor N, Tarwater PM, Skolasky RL, et al.: CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing. Neurology 2001;57:542-544.
20. Gaidano G, Carbone A, and Dalla-Favera R: Pathogenesis of AIDS-related lymphomas. Molecular and histogenetic heterogeneity. Am J Pathol 1998;152:623-630.